References
- Perea G, Sureda A, Martino R, Altes A, Martinez C, Cabezudo E, . Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Ann Hematol 2001;80:592–7.
- Kuittinen T, Nousiainen T, Halonen P, Mahlamaki E, Jantunen E. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 2004;33: 907–12.
- Sinha S, Gastineau D, Micallef I, Hogan W, Ansell S, Buadi F, . Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention. Bone Marrow Transplant 2011;46:943–9.
- Lefrere F, Makki J, Marolleau JP, Dal Cortivo L, Alberti C, Benbunan M, . CD34+ cells during leukapheresis procedures: relationship of volume processed and quantity of peripheral blood progenitor cells collected. Transfusion. 2000;40:493–5.
- Basquiera AL, Abichain P, Damonte JC, Ricchi B, Sturich AG, Palazzo ED, . The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation. J Clin Apher. 2006;21:92–5.
- Lefrere F, Zohar S, Beaudier S, Audat F, Ribeil JA, Ghez D, . Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis. Transfusion. 2007;47:1851–7.
- Delamain MT, Marques JFC Jr, De Souza CA, Lorand-Metze I, Metze K. An algorithm based on peripheral CD34+ cells and hemoglobin concentration provides a better optimization of apheresis than the application of a fixed CD34 threshold. Transfusion. 2008;48:1133–7.
- Costa LJ, Alexander ET, Hogan KR, Schaub C, Fouts TV, Stuart RK. Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization. Bone Marrow Transplant 2011;46:64–9.
- Gidron A, Singh V, Egan K, Mehta J. Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be. Bone Marrow Transplant 2008;42:439–42.
- Chin-Yee I, Keeney M, Anderson L, Nayar R, Sutherland DR. Current status of CD34+ cell analysis by flow cytometry: the ISHAGE guidelines. Clin Immunol Newsletter. 1997;17:21–9.
- Pineiro G, Perelman S, Guerschman JP, Paruelo JM. How to evaluate models: Observed vs. predicted or predicted vs. observed? Ecological Modelling 2008;216:316–22.
- Meehan KR, Hill JM, Patchett L, Webber SM, Wu J, Ely P, . Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization. Transfusion. 2006;46:523–9.
- Gertz MA, Wolf RC, Micallef IN, Gastineau DA, . Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma. Bone Marrow Transplant 2010;45:1396–403.
- Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz MJ, . Effectiveness and cost analysis of “just-in-time” salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion. 2011;51:2175–82.